Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2018 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

RUTHERFORD, N.J. and JERUSALEM, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through...
August 14, 2018 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers...
August 07, 2018 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018

RUTHERFORD, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
July 18, 2018 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Closes $2.625 million Convertible Note Financing

RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
June 12, 2018 08:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer

RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
May 15, 2018 07:00 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
May 10, 2018 16:05 ET | Source: Cancer Genetics, Inc.

Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018

RUTHERFORD, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
April 27, 2018 08:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated

RUTHERFORD, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
April 16, 2018 07:30 ET | Source: Cancer Genetics, Inc.

Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance

RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...
April 02, 2018 16:01 ET | Source: Cancer Genetics, Inc.

Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates

RUTHERFORD, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today...